Analytical Testing Services
World-Class Analytical Services, Supporting your New Product Development Programs
All the expert support you need
Whether it’s a full analytical support package or additional resources to supplement your in-house capabilities, our global network is ready to support you.
Access to unsurpassed expertise
Our experts in chemistry, biochemistry, material science and forensic science combine their knowledge in materials, drug development systems and compatibility issues to support your product development, quickly and with less risk to your project.
Capacity, capability and compliance
Featuring a complete range of analytical tests, including scale-up and manufacturing, our laboratories are cGMP-compliant, FDA-inspected, ISO 17025-accredited and EQFAR-certified through ANVISA.
For every therapy and every eventuality
Covering different therapeutic areas as well as the main routes of administration, we understand your APIs, drug substances and your formulation challenges, in order to help you navigate the constantly evolving regulatory landscape.
Support for Every Stage of Your Development Journey
Extractables and Leachables
Extractable and Leachable testing is to identify packaging related impurities in components, raw material drug products and equipment. These tests are important for both regulatory compliance and patient safety.
Particle Detection and Analysis for Injectable Drugs
The presence of particles and their analysis can affect the safety and quality of parenteral drugs as particles can be potentially harmful to patients. Managing contaminant issues during the manufacturing process can reduce the risk of future contamination and potentially avoid costly product recalls.
Visual Inspection Support during Manufacturing
Visual inspection during the manufacturing process of drug products is important to ensure both patient safety and cost effective supply. This is especially true for parenteral & ophthalmic medications.
Container Closure Integrity Testing (CCIT)
This nondestructive procedure evaluates the ability of the container closure system to maintain a suitable barrier against potential contaminants (e.g. microorganisms, oxygen, etc…). This evaluation is important for patients’ safety and/or drug product stability.
Glass Delamination Testing and Analysis
Glass delamination testing is necessary to analyze the durability of glass containers and their interactions with specific drug products.
In the development of pMDIs and nasal sprays, particle/droplet size and spray pattern or plume are two of the most significant factors that affect the deposition of the sprays in the mouth and nose cavities.
Aerosol characterization tests for inhaled products are important to determine the dose emitted, particle size, purity of the API as well as various stresses on the device such as mechanical shock, vibration, and light exposure.
Drug dissolution testing is used to provide in vitro drug release information for both quality control purposes, i.e., to assess batch-to-batch consistency of solid oral dosage forms such as tablets, and drug development, i.e., to predict in vivo drug release profiles.
Performance and Packaging Delivery Systems
Several tests are used during the design and development of drug delivery devices to test their ‘fitness for intended use’. One such test is the actuation force.
Nasal Cast Deposition Tests
These tests help quantify the deposition of a nasally administered drug in the various regions of the nasal cavity.
Bioequivalance Testing and Biowaver Support
Bioequivalence testing is used to compare the performance of two different versions of a particular drug product (e.g. generic vs. originator). This testing can be performed in vitro or in vivo. The use of clinically relevant in vitro testing brings opportunities to de-risk complex and expensive clinical studies.
Batch Releases/Certificates of Analysis
We provide official certificates for each batch to attest that the product supplied meets all relevant specifications. This certificate typically details product specifications, the analytical methods used and the analytical results obtained.
Latest in Aptar Pharma Knowledge Hub
Aptar Pharma Acquires Orbital™ Dry Powder Inhaler (DPI) License
Press Releases, Pharmaceutical, Device Innovations, Brand Differentiation, Product Solutions
Nasal Drug Delivery: Beyond Hayfever
Webinars, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions
Digital Health and Digital Therapeutics: Where are we heading and...
Webinars, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions
How pMDIs are transforming Asthma and COPD treatments
Publications, Pharmaceutical, Sustainability, Device Innovations, Market Insights, Product Solutions